电邮这篇文章 Two-step therapy of infectious and inflammatory diseases: Clinician and lawyer views. A review
- 作者: Apolikhina I.A.1,2, Tarnaeva L.A.1, Latfullina E.Z.1, Gabay P.G.3,4,5,6
-
隶属关系:
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Sechenov First Moscow State Medical University (Sechenov University)
- Faculty of Medical Law LLC
- Foundation for the Support of Anticancer Organizations “Together Against Cancer”
- National Analytical and Expert Center for Healthcare ANO
- Federal Research and Clinical Center of Medical Rehabilitation and Balneology
- 期: 卷 27, 编号 1 (2025)
- 页面: 66-72
- 栏目: REVIEW
- URL: https://journal-vniispk.ru/2079-5831/article/view/290986
- DOI: https://doi.org/10.26442/20795696.2025.1.203159
- ID: 290986
如何引用文章
全文:
详细
Infectious and inflammatory diseases are significant healthcare problems exacerbated by the increase in antibiotic resistance in pathogens. The ineffectiveness of traditional antibacterial therapy leads to prolonged infections, complications, and decreased patient quality of life. The article discusses the urgency of the problem of antibacterial drug use and reviews, from a clinical and legal point of view, the prospects for the use of enzyme-based agents as additional therapy. The mechanisms of action of enzymes, their potential effectiveness against resistant pathogens, the prevention of complications, and the possibility of combined use with antibiotics, considering legal and medical aspects, are discussed. The results of the studies demonstrate the prospects of using enzyme therapy to reduce the severity of the inflammatory process, improve the microbiocenosis state, increase the effectiveness of antibacterial therapy, and prevent complications of infectious and inflammatory diseases in gynecological practice. There is a legal justification for applying certain measures to prevent complications.
作者简介
Inna Apolikhina
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: i_apolikhina@oparina4.ru
ORCID iD: 0000-0002-4581-6295
D. Sci. (Med.), Prof.
俄罗斯联邦, Moscow; MoscowLiana Tarnaeva
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: i_apolikhina@oparina4.ru
ORCID iD: 0009-0006-7500-7516
obstetrician-gynecologist, Graduate Student
俄罗斯联邦, MoscowElina Latfullina
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: i_apolikhina@oparina4.ru
ORCID iD: 0009-0004-6586-7788
Medical Resident
俄罗斯联邦, MoscowPolina Gabay
Faculty of Medical Law LLC; Foundation for the Support of Anticancer Organizations “Together Against Cancer”; National Analytical and Expert Center for Healthcare ANO; Federal Research and Clinical Center of Medical Rehabilitation and Balneology
Email: i_apolikhina@oparina4.ru
ORCID iD: 0000-0002-0388-1304
Cand. Sci. (Law)
俄罗斯联邦, Moscow; Moscow; Moscow; Moscow参考
- Савичева А.М., Соколовский Е.В., Тапильская Н.И., и др. Инфекционно-воспалительные заболевания в акушерстве и гинекологии: руководство для врачей. Под ред. Э.К. Айламазяна. М.: ГЭОТАР-Медиа, 2016 [Savicheva AM, Sokolovskii EV, Tapil'skaia NI, et al. Infektsionno-vospalitel'nye zabolevaniia v akusherstve i ginekologii: rukovodstvo dlia vrachei. Pod red. E.K. Ailamaziana. Moscow: GEOTAR-Media, 2016 (in Russian)].
- Воспалительные болезни шейки матки, влагалища и вульвы. Проект клинических рекомендаций Минздрава России 2024. Режим доступа: https://roag-portal.ru/projects_gynecology. Ссылка активна на 05.06.2023 [Vospalitel'nye bolezni sheiki matki, vlagalishcha i vul'vy. Proekt klinicheskikh rekomendatsii Minzdrava Rossii 2024. Available at: https://roag-portal.ru/projects_gynecology. Accessed: 05.06.2023 (in Russian)].
- World Health Organization. Guidelines for the Management of Symptomatic Sexually Transmitted Infections. WHO; Geneva, Switzerland, 2021. Available at: https://www.who.int/publications/i/item/9789240024168. Accessed: 05.06.2023.
- Cannovo N, Bianchini E, Gironacci L, et al. Sexually Transmitted Infections in Adolescents and Young Adults: A Cross Section of Public Health. Int J Environ Res Public Health. 2024;21(4):501. doi: 10.3390/ijerph21040501
- Mitchell CM, Anyalechi GE, Cohen CR, et al. Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia. J Infect Dis. 2021;224(12 Suppl. 2):29-35. doi: 10.1093/infdis/jiab067
- Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis. 2011;38(9):879-81. doi: 10.1097/OLQ.0b013e31821f918c
- Singh N, Sethi A. Endometritis – Diagnosis, Treatment and its impact on fertility – A Scoping Review. JBRA Assist Reprod. 2022;26(3):538-46. doi: 10.5935/1518-0557.20220015
- Kitaya K, Takeuchi T, Mizuta S, et al. Endometritis: new time, new concepts. Fertil Steril. 2018;110(3):344-50. doi: 10.1016/j.fertnstert.2018.04.012
- Gaspar C, Rolo J, Cerca N, et al. Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms. Pathogens. 2021;10(3):261. doi: 10.3390/pathogens10030261
- Castro J, Lima Â, Sousa LGV, et al. Crystal Violet Staining Alone Is Not Adequate to Assess Synergism or Antagonism in Multi-Species Biofilms of Bacteria Associated With Bacterial Vaginosis. Front Cell Infect Microbiol. 2021;11:795797. doi: 10.3389/fcimb.2021.795797
- Zhao A, Sun J, Liu Y. Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol. 2023;13:1137947. doi: 10.3389/fcimb.2023.1137947
- Ivanova K, Fernandes MM, Francesko A, et al. Quorum-Quenching and Matrix-Degrading Enzymes in Multilayer Coatings Synergistically Prevent Bacterial Biofilm Formation on Urinary Catheters. ACS Appl Mater Interfaces. 2015;7(49):27066-77. doi: 10.1021/acsami.5b09489
- Tan Y, Ma S, Leonhard M, et al. Co-immobilization of cellobiose dehydrogenase and deoxyribonuclease I on chitosan nanoparticles against fungal/bacterial polymicrobial biofilms targeting both biofilm matrix and microorganisms. Mater Sci Eng C Mater Biol Appl. 2020;108:110499. doi: 10.1016/j.msec.2019.110499
- Perwez M, Mazumder JA, Noori R, Sardar M. Magnetic combi CLEA for inhibition of bacterial biofilm: A green approach. Int J Biol Macromol. 2021;186:780-8. doi: 10.1016/j.ijbiomac.2021.07.091
- Устюжанин А.В., Чистякова Г.Н., Ремизова И.И. Изучение влияния ферментного препарата Вобэнзим на процесс формирования биопленок штаммов бактерий. Антибиотики и Химиотерапия. 2024;69(1-2):10-4 [Ustyuzhanin AV, Chistyakova GN, Remizova II. Study of the Wobenzym Enzyme Preparation Effect on the Formation of Bacterial Biofilms. Antibiotics and Chemotherapy. 2024;69(1-2):10-4 (in Russian)].
- Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther. 2011;9(1):61-70. doi: 10.1586/eri.10.156
- Сурцова Е.А., Опруженков А.В. Особенности ультразвуковой диагностики хронического воспаления матки. В: Актуальные вопросы акушерства и гинекологии: сборник материалов внутривузовской научно-практической конференции. Ростов н/Д: Ростовский государственный медицинский университет, 2023 [Surtsova EA, Opruzhenkov AV. Osobennosti ul'trazvukovoi diagnostiki khronicheskogo vospaleniia matki. V: Aktual'nye voprosy akusherstva i ginekologii: sbornik materialov vnutrivuzovskoi nauchno-prakticheskoi konferentsii. Rostov-on-Don: Rostovskii gosudarstvennyi meditsinskii universitet, 2023 (in Russian)].
- Прилепская В.Н., Яглов В.В. Воспалительные заболевания органов малого таза. М.: ГЭОТАР-Медиа, 2010 [Prilepskaia VN, Iaglov VV. Vospalitel'nye zabolevaniia organov malogo taza. Moscow: GEOTAR-Media, 2010 (in Russian)].
- Сухих Г.Т., Шуршалина А.В. Хронический эндометрит. М.: ГЭОТАР-Медиа, 2013 [Sukhikh GT, Shurshalina AV. Khronicheskii endometrit. Moscow: GEOTAR-Media, 2013 (in Russian)].
- Воспалительные болезни женских тазовых органов. 2024. Клинические рекомендации. Режим доступа: https://cr.minzdrav.gov.ru/view-cr/643_2 Ссылка активна на 05.06.2023 [Vospalitel'nye bolezni zhenskikh tazovykh organov. 2024. Klinicheskie rekomendatsii. Available at: https://cr.minzdrav.gov.ru/view-cr/643_2. Accessed: 05.06.2023 (in Russian)].
- Гинекология. Под ред. В.Е. Раздинского. М.: ГЭОТАР-Медиа, 2013 [Ginekologiia. Pod red. V.E. Razdinskogo. Moscow: GEOTAR-Media, 2013 (in Russian)].
- Прилепская В.Н., Яглов В.В. Воспалительные заболевания органов малого таза. М.: ГЭОТАР-Медиа, 2010 [Prilepskaia VN, Iaglov VV. Vospalitel'nye zabolevaniia organov malogo taza. Moscow: GEOTAR-Media, 2010 (in Russian)].
- Прилепская В.Н., Межевитинова Е.А., Абакарова П.Р., и др. Эффективность и приемлемость системной энзимотерапии в комплексном лечении вульвовагинита, вызванного условно-патогенными микроорганизмами. Результаты рандомизированного исследования. Гинекология. 2024;26(3):200-9 [Prilepskaya VN, Mezhevitinova EA, Abakarova PR, et al. The effectiveness and acceptability of systemic enzyme therapy in the complex treatment of vulvovaginitis caused by opportunistic microorganisms: Open-label single-center prospective comparative randomized study. Gynecology. 2024;26(3):200-9 (in Russian)]. doi: 10.26442/20795696.2024.3.202867
- Аполихина И.А. Роль системной энзимотерапии препаратом Флогэнзим в профилактике послеоперационных осложнений в гинекологической практике. Фарматека. 2023;30(4-5):133-7 [Apolikhina IA. The role of systemic enzyme therapy with Phlogenzym in the prevention of postoperative complications in gynecological practice. Farmateca. 2023;30(4-5):133-7 (in Russian)]. doi: 10.18565/pharmateca.2023.4-5.133-137
- Подзолкова Н.М., Фадеев И.Е., Кузнецов Р.Э., Полетова Т.Н. Дискуссионные вопросы антибиотикотерапии и системной энзимотерапии воспалительных заболеваний органов малого таза. Гинекология. 2024;26(4):318-24 [Podzolkova NM, Fadeev IE, Kuznetsov RE, Poletova TN. Discussions on antibiotic therapy and systemic enzyme therapy for pelvic inflammatory disease: A review. Gynecology. 2024;26(4):318-24 (in Russian)]. doi: 10.26442/20795696.2024.4.202897
- Доброхотова Ю.Э., Маркова Э.А., Косик Н.В., и др. Терапия неспецифического цервицита в сочетании с дисплазией шейки матки. Результаты многоцентрового наблюдательного исследования.
- Куприянов Ю.A., Зайцев А.В., Берников А.Н., и др. Эффективность препарата Вобэнзим в комбинированной терапии хронического бактериального простатита. Результаты систематического обзора и метаанализа. Урологические ведомости. 2024;14(1):51-64 [Kupriyanov YuA, Zaitsev AV, Bernikov AN, et al. Effectiveness of Wobenzym in combined therapy of chronic bacterial prostatitis. Results of systematic review and meta-analysis. Urology reports (St. Petersburg). 2024;14(1):51-64 (in Russian)]. doi: 10.17816/uroved626639
- Biziulevicius GA. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point. Med Hypotheses. 2006;67(6):1386-8. doi: 10.1016/j.mehy.2006.05.051
- Нурмаков А.Ж., Баймухамедов А.А., Надыров М.Т. Эффективность полиэнзимного препарата Вобэнзим плюс в хирургии. Медицина. 2016;6:22-8 [Nurmakov AZh, Baimukhamedov AA, Nadyrov MT. Effektivnost' polienzimnogo preparata Vobenzim plius v khirurgii. Meditsina. 2016;6:22-8 (in Russian)].
补充文件
